Want to see JP:6368 full AI Analyst Report?
Top Page
Organo Corp.
(6368)
Select Model
Select Model
Rating:74Outperform
Price Target:
¥2,467.00
▼(-81.57% Downside)
Action:Upgraded
Date:09/30/26
The score is primarily supported by strong financial performance (notable margin expansion and improved profitability) and an attractive dividend yield. These positives are tempered by weaker technicals (below key longer-term moving averages with negative MACD) and some financial risk flags from rising debt and historically volatile cash flow.
Positive Factors
Margin Expansion
Sustained expansion in gross and net margins indicates that Organo has materially improved its earnings economics over several years. This strengthens internal funding capacity, supports resilience against cost pressure, and suggests profitability can remain a durable competitive advantage if operating discipline continues.
Negative Factors
Recent Debt Increase
The recent increase in borrowing adds a lasting constraint to financial flexibility even though leverage remains manageable. Organo will need continued earnings and cash-flow strength to keep debt risk contained, while higher obligations may limit room for investment or shareholder distributions during weaker periods.
Read all positive and negative factors
Positive Factors
Negative Factors
Margin Expansion
Sustained expansion in gross and net margins indicates that Organo has materially improved its earnings economics over several years. This strengthens internal funding capacity, supports resilience against cost pressure, and suggests profitability can remain a durable competitive advantage if operating discipline continues.
Read all positive factors
Organo Corp. (6368) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥509.50B
Dividend Yield9.76%
Average Volume (3M)1.24M
Price to Earnings (P/E)18.0
Beta (1Y)1.89
Revenue Growth7.05%
EPS Growth12.23%
CountryJP
Employees2,658
SectorGeneral
Sector StrengthN/A
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)122.64
Shares Outstanding231,798,500
10 Day Avg. Volume1,113,260
30 Day Avg. Volume1,244,743
Financial Highlights & Ratios
PEG Ratio1.25
Price to Book (P/B)4.38
Price to Sales (P/S)3.52
P/FCF Ratio21.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)134.39
Revenue Forecast (FY)¥203.90B
Organo Corp. Business Overview & Revenue Model
Company Description
Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and known as Japan Organo Co., Ltd. until its name change in 1966), is a global specialist in water treatment engineering. The company's business activities are structured i...
How the Company Makes Money
null...
Organo Corp. Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 181.73B | 177.65B | 163.27B | 150.36B | 132.43B | 112.07B |
| Gross Profit | 65.74B | 65.08B | 55.18B | 43.84B | 34.98B | 28.51B |
| EBITDA | 40.67B | 40.59B | 34.53B | 25.88B | 18.02B | 14.15B |
| Net Income | 28.20B | 28.40B | 24.15B | 17.31B | 11.73B | 9.21B |
Balance Sheet | ||||||
| Total Assets | 221.71B | 224.87B | 194.40B | 182.70B | 164.85B | 130.51B |
| Cash, Cash Equivalents and Short-Term Investments | 27.84B | 31.05B | 16.75B | 17.64B | 15.56B | 20.20B |
| Total Debt | 37.36B | 34.40B | 22.73B | 36.67B | 33.25B | 15.87B |
| Total Liabilities | 79.81B | 81.90B | 73.20B | 80.55B | 78.48B | 54.50B |
| Stockholders Equity | 141.89B | 142.96B | 120.95B | 101.93B | 86.17B | 75.84B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 29.37B | 26.54B | 20.50B | -21.18B | 8.29B |
| Operating Cash Flow | 0.00 | 31.44B | 28.80B | 21.69B | -19.98B | 10.79B |
| Investing Cash Flow | 0.00 | -2.74B | -2.13B | -1.42B | -1.31B | -1.52B |
| Financing Cash Flow | 0.00 | 3.12B | -20.82B | -641.00M | 14.71B | -2.59B |
Organo Corp. Technical Analysis
Negative
13385.00
Price Trends
2517.26
Negative
2789.21
Negative
2952.34
Negative
Market Momentum
-85.79
Positive
35.04
Neutral
43.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6368, the sentiment is Negative. The current price of 13385 is above the 20-day moving average (MA) of 2496.42, above the 50-day MA of 2517.26, and above the 200-day MA of 2952.34, indicating a bearish trend. The MACD of -85.79 indicates Positive momentum. The RSI at 35.04 is Neutral, neither overbought nor oversold. The STOCH value of 43.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6368.
Organo Corp. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥509.50B | 17.96 | ― | 9.76% | 7.05% | 12.23% | |
69 Neutral | ¥63.23B | 7.38 | 18.12% | 5.00% | 25.38% | 31.89% | |
68 Neutral | ¥215.93B | 14.31 | 13.96% | 3.64% | 17.65% | 72.55% | |
65 Neutral | ¥161.54B | 18.79 | 9.89% | 2.43% | 12.87% | -13.63% | |
59 Neutral | ¥601.86B | 24.94 | 7.24% | 2.18% | 0.99% | 24.98% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | ¥172.24B | 11.57 | ― | 2.45% | 7.67% | -30.19% |
* General Sector Average
JP:6368
Organo Corp.
2,202.50
-411.69
-15.75%
JP:6370
Kurita Water Industries
5,647.00
-118.14
-2.05%
JP:9551
METAWATER Co
3,700.00
464.52
14.36%
JP:6013
Takuma Co
2,967.00
687.46
30.16%
JP:6331
Mitsubishi Kakoki Kaisha,Ltd.
2,698.00
-460.71
-14.59%
JP:7004
Hitachi Zosen Corporation
1,022.00
-95.34
-8.53%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.